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Abstract
Background: Purulent pericarditis is an infectious disease, frequently caused by gram-positive bacteria, that is rarely
observed in healthy individuals, and is often associated with predisposing conditions.
Case presentation: Here, we present the case of an Escherichia coli post-surgical localized purulent pericarditis
complicated by transient constrictive pericarditis and its diagnostic and therapeutic management.
Conclusions: Our case report focuses on the importance of imaging-guided treatment of purulent pericardial
diseases, in particular on the emerging role of 18 F-labelled 2-fluoro-2-deoxy-D-glucose Positron Emission
Tomography/Computed Tomography in pericardial diseases and on the management of transient constrictive
pericarditis, often seen after thoracic surgery.
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Background
Purulent pericarditis is defined as the presence of gross
pus in the pericardium or microscopic purulence, fre-
quently due to an infective agent; when localized, it be-
comes a pericardial abscess [1]. Today, in the antibiotic
era, purulent pericarditis is rarely observed in healthy
adults and the very few reported cases were associated
with predisposing factors (immunodeficiency, alcohol
abuse, cardiac surgery and chronic renal failure). The
main cause is gram-positive bacteria and the typical clin-
ical presentation is acute, with haemodynamic instability
[2]. Clinical presentation might be subacute or chronic,
usually caused by Mycobacterium tuberculosis [3]. How-
ever, uncommon cases of subacute purulent pericarditis
due to Escherichia (E.) coli infection in patients with
predisposing factors have been described [4]. We report
a case of E. coli pericardial abscess in a patient who
underwent cardiac surgery complicated by pericardial
constriction.
Case presentation
In August 2017, a 61-year old man with multiple cardio-
vascular risk factors – obesity (BMI 30.8 kg/m2), hyper-
tension and hypercholesterolemia - underwent aortic
valve replacement with a mechanical prosthetic valve for
severe aortic stenosis. After surgery, the patient devel-
oped a persistent pericardial effusion and was discharged
with steroidal therapy. Thereafter, the patient developed
type 2 diabetes mellitus. Three months after surgery, the
patient complained of exercise dyspnea with no clinical
and laboratory signs of active infection. Transthoracic
echocardiogram showed persistent pericardial effusion.
In presence of post-pericardiotomy syndrome after car-
diac surgery, an anti-inflammatory therapy with ibupro-
fen and colchicine was added on top of chronic steroidal
therapy.
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In February 2018, he was referred to our hospital for
rapidly worsening dyspnoea and lower limb oedema des-
pite pharmacologic therapy. The patient denied fever
and had no signs of haemodynamic instability, but the
jugular venous pressure was about 12 cm H2O. His pul-
monary examination was remarkable due to a decrease
in breath sounds in both lung bases. Laboratory studies
revealed elevated inflammatory markers (White Blood
cell Count (WBC) 13,226/mmc, C-Reactive Protein
(CRP) 13.91 mg/dl, Procalcitonin (PCT) 1.5 ng/ml).
A transthoracic echocardiogram showed a loculated
pericardial effusion with signs of restrictive physi-
ology, normal left ventricular function and no signs
of valve dysfunction. Cardiac Computed Tomography
(CT) confirmed the echocardiographic findings
(Fig. 1a). To exclude an active infection, 18 F-labelled
2-fluoro-2-deoxy-D-glucose Positron Emission Tom-
ography/Computed Tomography (18F-FDG PET/CT)
was performed and revealed a selective hypercaptation
of the tracer at the walls of the pericardial effusion
(SUV max = 11) (Fig. 1d). Despite the selective cardiac
hypercaptation on 18F-FDG PET/CT, urinary and
blood cultures, abdominal ultrasound and pancolon-
scopy were performed and excluded other sources of
infection.
Because of the location of the pericardial effusion,
video-assisted thoracic surgery pericardial drainage was
planned. During the procedure, pleural empyema and a
pericardial abscess were revealed, so a conversion to a
mini-thoracotomy approach was necessary in order to
perform pericardiotomy and pleural decortication. After
broad-spectrum antibiotic therapy, an amoxicillin-
sensitive E. coli was isolated from the pericardial fluid,
so targeted intravenous antibiotics were continued for 2
weeks. The patient was discharged with oral amoxicillin/
clavulanate therapy aiming to complete a 4-week
therapy.
In April 2018, the patient presented to the emergency
department complaining of a high fever, worsening dys-
pnoea and lower limb oedema. An urgent CT scan re-
vealed a paracardiac egg-shaped fluid collection (Fig.
1b). Laboratory tests only showed a mild elevation of in-
flammatory markers (WBC 11.780/mmc, CRP 5.1 mg/dl,
PCT 0.4 ng/ml). Empiric broad-spectrum antibiotic ther-
apy and high dose diuretic therapy were started, and the
patient was transferred to the Cardiology Department.
The echocardiogram showed a left postero-lateral fluid
collection, without diffuse pericardial effusion. Cardiac
magnetic resonance confirmed a non-homogeneous fluid
collection, thick walls picking up contrast medium and
Fig. 1 Thoracic computed tomography and 18 F-labeled 2-fluoro-2-deoxy-D-glucose positron emission tomographic/computer tomography
imaging. In the upper series of figures, thoracic computed tomography scan sections acquired in February 2018 (a), April 2018 (b) and October
2018 (c), respectively, are shown. (a) Severe loculated pericardial effusion localized to the lateral wall of the left ventricle (51 mm) and bilateral
pleural effusion. (b) Paracardiac egg-shaped fluid collection (38 × 27 mm) with peripheric hypercaptation of the tracer. (c) Mild diffuse postero-
lateral pericardial effusion (maximal thickness: 11 mm). No evidence of persistence of localized fluid collection. In the lower series, 18 F-labeled 2-
fluoro-2-deoxy-D-glucose positron emission tomographic/computer tomography (18F-FDG PET/CT) sections acquired in February 2018 (d), April
2018 (e) and April 2019 (f) are presented. d Pathological hypercaptation at the walls of the pericardial effusion (SUV max = 11). e In comparison
with previous 18F-FDG PET/CT, the area of tracer hypercaptation in left paracardiac position is reduced in dimension, but stable in intensity (SUV
max = 9.6). d Normalization of the area of metabolic hypercaptation reported in the previous exams
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septal bounce. An 18F-FDG PET/CT revealed a persist-
ence of tracer hypercaptation in the left paracardiac pos-
ition (SUV 9.6 max) (Fig. 1e).
Due to the persistence of haemodynamic impairment,
the patient underwent surgical excision of the pericardial
abscess and partial pericardiectomy through a sternotomy
approach. As shown in Fig. 2a the histological analysis
demonstrated an underlying chronical inflammation
process with fibrosis and mesothelial hyperplasia (Fig. 2b)
and inflammatory infiltrate rich in macrophages (Fig. 2c).
In the absence of microbial growth at microbiological
exams, E. coli targeted intravenous antibiotic therapy was
continued.
In considerations of the persistence of fluid overload
and the new onset of signs of pericardial constriction at
echocardiograms, high dose diuretic treatment and col-
chicine were successfully administered.
The patient was discharged home with long-term oral
antibiotic therapy and colchicine.
At the 6- and 12-month evaluations, the patient was
asymptomatic, without any symptoms of fluid overload
or echocardiographic signs of constrictive physiology. A
6-month CT scan revealed the persistence of mild dif-
fuse pericardial effusion without any sign of pericardial
abscess (Fig. 1c). A 12-month 18-FDG-PET did not
show any hypercaptation of the tracer in the cardiac area
(Fig. 1f).
Discussion and conclusions
Despite optimized surgical technique and perioperative
antibiotic prophylaxis, the incidence of infection after
cardiac operations is still high [5]. We have described an
unusual case of E. coli pericardial abscess in a post-
surgical patient. The most common organism that
causes purulent pericarditis is Staphylococcus aureus.
Other frequently isolated bacteria are Neisseria meningi-
tidis and Streptococcus pneumoniae. Gram-negative rods,
Pseudomonas aeruginosa, Salmonella, anaerobes, and
fungal pathogens are less common [6]. The literature
contains few case-reports of purulent pericarditis due to
a very uncommon gram-negative bacillus as E. coli.
Sagrista-Sauleda et al. reported that in 33 patients with
purulent pericarditis only two were due to E. coli [7] and
usually develop in patients with cancer, in particular in
aggressive lymphomas [4].
The development of postoperative cardiac infection
may be due patient-related and procedure-related factors
[8]. In our case report the elements related to the peri-
cardial infection may be obesity and perhaps no optimal
hygienic standards to minimize the local bacterial
infection.
The clinical presentation in our patient was subacute/
chronic and differed from the acute manifestation of the
vast majority of purulent pericarditis due to Gram +
bacteria. This clinical evolution is probably typical of
E.coli pericarditis [4] or might be due to a concomitant
immunosuppression condition provoked by chronic
antinflammatory therapy - steroidal and non-steroidal
therapy - prescribed after cardiac surgery and the dia-
betic status. Our case report is the first described case of
pericardial abscess due to E. coli after cardiac surgery.
However, it is reported that purulent pericarditis is an
unusual complication of thoracic surgery. Pericarditis
may be present in the early post-operative period associ-
ated with a severe mediastinitis requiring re-operation
and drainage. Our patient was discharged with steroidal
and non-steroidal anti-inflammatory drugs, demonstrat-
ing that the pericarditis was already present, but it was
diagnosed as post-pericardiectomy.
In our case, a very careful work-up was essential in
guiding the diagnosis and treatment. In particular, 18F-
FDG PET/CT confirmed the persistence of the inflam-
mation. In heart studies, 18F-FDG PET/CT is used to
identify areas of viable myocardium and inflamed tissues
such as infiltrating inflammatory cells and infectious
foci. Its efficacy is due to the ability of 18F-FDG PET/CT
Fig. 2 Histological and immunohistochemical analysis. In a there is evidence of chronic inflammation with fibrosis, mesothelial hyperplasia and
mixed cellular infiltrate rich in macrophages, neutrophils, eosinophils and plasma cells. b shows the immunohistochemical analysis for Calretinin
that highlights mesothelial cells and their hyperplasia. c we can observed the immunohistochemical analysis for CD 68, a specific surface marker
of macrophages
Magnani et al. BMC Infectious Diseases          (2020) 20:342 Page 3 of 5
to dynamically penetrate activated leukocytes, macro-
phages, and CD4-positive T cells present at the sites of
infection. In parallel, recent studies have reported prom-
ising data for 18F-FDG PET/CT in the diagnosis of in-
fective endocarditis particularly in patients with
prosthetic valves and implantable cardiac electronic de-
vice infection as well as in the recognition of extracar-
diac complications [9]. The recent guidelines of the
European Society of Cardiology have included 18F-FDG
PET/CT as a diagnostic tool in the diagnostic algorithm
of prosthetic valve endocarditis [10].
A few studies and several case reports have demon-
strated that 18F-FDG PET/CT imaging provides a meas-
urement of inflamed tissues such as purulent
pericarditis. Intense 18F-FDG PET/CT uptake has been
described in tuberculous pericarditis on 18F-FDG PET/
CT [11]. Dong et al. reported that 18F-FDG PET/CT in
patients with purulent pericarditis had a greater intensity
of uptake as compared with idiopathic pericarditis. In
fact, in our patient’s 18F-FDG PET/CT the SUV max was
very high [12]. Despite pseudonormalised inflammatory
markers, the correct non-invasive imagines helped us in
deciding the correct management and the correct
follow-up.
Finally, constrictive physiology developed in our pa-
tient immediately after pericardiectomy with an urgent
need for intravenous diuretics and anti-inflammatory
drugs, but almost disappeared at follow-up. In fact, tran-
sient constrictive pericarditis is frequently described in
the literature after cardiac surgery and is related to the
presence of acute inflammation that provokes constrict-
ive symptoms and resolves after standard treatment for
acute pericarditis [13].
In conclusion, this case report highlights the importance
of the correct microbiological diagnosis in order to best
guide antimicrobial therapy and the central role of
imaging-guided treatment of purulent pericardial diseases.
We also reported the existence of a transient form of con-
strictive pericarditis, often seen after thoracic surgery,
which usually resolves with anti-inflammatory drugs.
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